Charles Edwards, MD
Orthopaedic Surgery of the Spine · Baltimore, MDNPI 1568572030
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $16,329 of the $16,574 with a category attached, or 98.5%. 7 manufacturers reported payments, led by Kyocera Medical Technologies, Inc. at 51.1% of the total. Reporting peaked in 2019 at $7,922 and has fallen 98.2% since, to $143 in 2023.
Across 9 payments — averaging $1841.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyocera Medical Technologies, Inc.$8K
- Renovis Surgical Technologies, Inc.$8K
- Zimvie Inc.$143
- Johnson & Johnson$40
- Si-bone, Inc.$36
- Smith+Nephew$15
- plus $11 from 1 others
Across 27 payments — averaging $39,227 each. An ownership or investment interest held by the physician or an immediate family member.
- Millennium Spine, LLC$653K
- Calvary Spine, LLC$407K
- Renovis Surgical Technologies, Inc.$0
What the payments were for
- Royalty or licence$16,32999%
- Food & beverage$2451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyocera Medical Technologies, Inc. | 3 | $8,469 |
| Renovis Surgical Technologies, Inc. | 1 | $7,860 |
| Zimvie Inc. | 1 | $143 |
| Johnson & Johnson | 1 | $40 |
| Si-bone, Inc. | 1 | $36 |
| Smith+Nephew | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mobi-C$143
How this compares
$16,574 in reported general payments places this provider in the 65th percentile of 49 orthopaedic surgery of the spine providers in Maryland.
See all orthopaedic surgery of the spine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 15 | $300 |
| Gabapentin | 20 | $202 |
| Methylprednisolone | 32 | $170 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Baltimore
- John CarboneBaltimore$25M
- Steven LudwigBaltimore$2.7M
- Paul McAfeeBaltimore$2.2M
- Amit JainBaltimore$250K
- Mesfin LemmaBaltimore$47K
- Daniel GelbBaltimore$40K
- Zan NaseerBaltimore$16K
- Maksim ShlykovBaltimore$14K
- Syed KarimBaltimore$12K
- David FalkBaltimore$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.